Citigroup »

Belite Bio shares owned by Citigroup

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $159 1 159.00
2025-03-31 $198 3 66.33

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio